A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its α-fluorinated analogue: Phase II metabolism and pharmacokinetics

Drug Metabolism and Disposition

Volumn 25, Issue 2, 1997, Pages 219-227

  Tang, Wei ^b   Abbott, Frank S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORO 2 PROPYL 4 PENTENOIC ACID; 2 PROPYL 2,4 PENTADIENOIC ACID; 2 PROPYL 4 PENTENOIC ACID; ACETYLCYSTEINE DERIVATIVE; DRUG METABOLITE; UNCLASSIFIED DRUG; VALPROIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG URINE LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; BIOTRANSFORMATION; FATTY ACIDS, MONOUNSATURATED; HALF-LIFE; LIVER; MALE; METABOLIC CLEARANCE RATE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; VALPROIC ACID;

ANIMALIA;

EID: 0031017391     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. T. A. Baillie and A. W. Rettenmeier: Valproate: Biotransformation. In "Antiepileptic Drugs" (R. H. Levy, R. H. Mattson, B. S. Meldrum, and J. K. Penry, eds.), pp. 601-619. Raven Press, New York, 1989.
2. A. E. Rettie, A. W. Rettenmeier, W. N. Howald, and T. A. Baillie: Cytochrome P-450 catalyzed formation of 4-ene VPA, a toxic metabolite of valproic acid. Science 235, 890-893 (1987).
3. N. Gerber, R. G. Dickinson, R. C. Harland, R. K. Lynn, D. Houghton, J. I. Antonias, and J. C. Schimschock: Reye-like syndrome associated with valproic acid therapy. J. Pediatr. 95, 142-144 (1979).
4. H. J. Zimmerman and K. G. Ishak: Valproate-induced hepatic injury: analysis of 23 fatal cases. Hepatology 2, 591-597 (1982).
5. K. Kassahun, K. Farrell, and F. Abbott: Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. Drug Metab. Dispos. 19, 525-535 (1991).
6. D. J. Reed: Glutathione: Toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631 (1990).
7. T. A. Baillie: Metabolic activation of valproic acid and drug-mediated hepatotoxicity: Role of the terminal olefin, 2-n-propyl-4-Pentenoic acid. Chem. Res. Toxicol. 1, 195-199 (1988).
8. J. W. Kesterson, G. R. Granneman, and J. Machinist: The hepatotoxicity of valproic acid and its metabolites in rats: I. toxicologic, biochemical and histopathologic studies. Hepatology 4, 1143-1152 (1984).
9. K. Kassahun, P. Hu, M. P. Grillo, M. R. Davis, L. Jin, and T. A. Baillie: Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and independent processes. Chem. Biol. Interact. 90, 253-275 (1994).
10. W. Tang and F. S. Abbott: Characterization of thiol conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry. J. Mass Spectrom. 31, 926-936 (1996).
11. W. Tang, A. G. Borel, T. Fujimiya, and F. S. Abbott: Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status. Chem. Res. Toxicol. 8, 671-682 (1995).
12. W. Tang, A. G. Borel, and F. S. Abbott: Conjugation of glutathione with a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, catalyzed by rat hepatic glutathione S-transferases. Drug Metab. Dispos. 24, 436-446 (1996).
13. D. Yu, J. D. Gordon, J. Zheng, S. K. Panesar, K. W. Riggs, D. W. Rurak, and F. S. Abbott: Determination of valproic acid and its metabolites using gas chromatography with mass selective detection: application to serum and urine samples from sheep. J. Chromatogr. 666, 269-281 (1995).
14. R. Curci, M. Fiorentino, L. Troisi, J. O. Edwards, and R. H. Pater: Epoxidation of alkenes by dioxirane intermediates generated in the reaction of potassium caroate with ketones. J. Org. Chem. 45, 4758-4760 (1980).
15. F. S. Abbott and A. A. Acheampong: Quantitative structure-anticonvulsant activity relationships of valproic acid, related carboxylic acids and tetrazoles. Neuropharmacology 27, 287-294 (1988).
16. P.E. Keane, J. Simiand, E. Mendes, V. Santucci, and M. Morre: The effects of analogues of valproic acid on seizures induced by pentylenetetrazol and GABA content in brain of mice. Neuropharmacology 22, 875-879 (1983).
17. W. Tang, G. Eigendorf, and F. S. Abbott: The metabolism of fluorinated VPA analogs. Proceedings of the 42nd ASMS Conference on Mass Spectrometry and Allied Topics. San Francisco, CA , 562a-562b (1993).
18. K. Singh, J. M. Orr, and F. S. Abbott: Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4-pentenoic acid in the rat. Drug Metab. Dispos. 16, 848-852 (1988).
19. K. Yamaoka and T. Nakagawa: A nonlinear test squares program based on differential equations, MULTI(RUNGE). for microcomputers. J. Pharmacobio-Dyn. 6, 595-606 (1983).
20. H. J. Kupferberg: Valproate: Chemistry and methods of determination. In "Antiepileptic Drugs" (R. Levy, R. Mattson, B. Meldrum, J. K. Penry, and F. E. Dreifuss, eds.), pp. 577-582. Raven Press, Ltd., New York, 1989.
21. R. G. Dickinson, W. D. Hooper, and M. J. Eadie: pH-Dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug Metab. Dispos. 12, 247-252 (1984).
22. A. W. Rettenmeier, W. P. Gordon, K. S. Prickett, R. H. Levy, and T. A. Baillie: Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Drug Metab. Dispos. 14, 454-464 (1986).
23. J. T. Welch: The effects of selective fluorination on reactivity in organic and bioorganic chemistry. In "Selective fluorination in organic and bioorganic chemistry" (J.T. Welch (ed.), pp. 1-15. American Chemical Society, Boston, 1990.
24. A.G. Clark, L. Fischer, P. Millburn, R.L. Smith, and R.T. Williams: The role of gut flora in the enterohepatic circulation of stilboestrol in the rat. Biochem. J. 112, 17p-18p (1969).
25. H. J. Buehler, P. A. Katzman, and E.A. Diosy: Studies on β-glucuronidase from E. coli. Proc. Soc. Exp. Biol. Med. 76, 672-676 (1951).
26. J.-L. Steimer, Y. Plusquellec, A. Guillaume, and J.-F. Boisvieux: A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation. J. Pharm. Sci. 71, 297-302 (1982).
27. K. Singh, J. M. Orr, and F. S. Abbott: Pharmacokinetics and enterohepatic circulation of (E)-2-ene valproic acid in the rat. J. Pharmacobio-Dyn. 13, 622-627 (1990).
28. A. J. Hutt and J. Caldwell: Amino acid conjugation. In "Conjugation reactions in drug metabolism" (G.J. Mulder, ed.), pp. 273-305. Taylor & Francis Ltd, New York, 1990.
29. L. T. Webster, Jr., U. A. Siddiqui, S. V. Lucas, J. M. Strong, and J. J. Mieyal: Identification of separate acyl-CoA:glycine and acyl-CoA:L-glutamine N-acyltransferase activities in mitochondrial fractions from liver of Rhesus monkey and man. J. Biol. Chem. 251, 3352-3358 (1976).
30. G. R. Granneman, S. I. Wang, J. W. Kesterson, and J. M. Machinist: The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 4, 1153-1158 (1984).
31. M. Jurima-Romet, F. S. Abbott, W. Tang, H. S. Huang, and L. W. Whitehouse: Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. Toxicology. 112, 69-85 (1996).
32. D. M. Turnbull, A. J. Bone, K. Bartlett, P. P. Koundakjian, and H. S. A. Sherratt: The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochem. Pharmacol. 32, 1887-1892 (1983).
33. R. A. Harris, M. Swartzentruber, C.-M. Becker, S. A. McCune, H. Hu, and K. Popov: Metabolic effects of sequestration of hepatic mitochondrial coenzyme A by valproate and other carboxylic acids. In "Idiosyncratic reactions to valproate: Clinical risk patterns and mechanisms of toxicity" (R. H. Levy and J. K. Penry, eds.), pp. 97-103. Raven Press, Ltd., New York, 1991.
34. W. Tang and F. S. Abbott: Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation: LC/MS/MS characterization of the GSH-glucuronide diconjugates. Chem. Res. Toxicol. 9, 517-526 (1996).
35. P. R. Ortiz de Montellano: Cytochrome P-450 catalysis: Radical intermediates and dehydrogenation reactions. TiPS 10, 354-359 (1989).